In Section 2 of the PDR®, Brand and Generic Name Index, find another product name for each of the drugs on the Representative Drugs table on pages 437–440.
Representative Drugs for the Nervous and Sensory Systems
Category, Namea, and Route | Uses and Diseases | Actions | Usual Doseb and Special Instructions | Side Effects and Adverse Reactions | |||||||
Stimulants |
|
|
|
| |||||||
Methylphenidate (Ritalin) Oral | Attention deficit disorder in children, narcolepsy | Is a cerebral stimulant | 20–30 mg/day in divided doses for adults; 10 mg/day for children; adjusted individually | Nervousness, insomnia, seizures, hypersensitivity, palpitations | |||||||
Analgesics |
|
|
|
| |||||||
Hydrocodone with acetaminophen(Vicodin) Oral | Moderate to moderately severe pain | Hydrocodone produces analgesic action on the CNS by the opiate receptors; acetaminophen analgesic action produced by both peripheral and central mechanisms (Narcotic analgesic) | 5 mg/500 mg 1–2 tablets every 4–6 hours; 7.5 mg/750 mg 1 tablet every 4–6 hours (VicodinES) | Lightheadedness, dizziness, sedation, drowsiness, nausea, vomiting, respiratory depression related to dose | |||||||
Acetaminophen with codeine(Tylenol with Codeine) Oral | Mild to moderately severe pain | Inhibits CNS prostaglandin synthesis, producing analgesic effect (acetaminophen); attach to specific receptors located in the central nervous system, resulting in various CNS effects, which decrease pain impulses (codeine) (Narcotic analgesic) | 1 or 2 tablets every 4–6 hours | Dizziness, headache, nausea, vomiting, constipation, rash | |||||||
Propoxyphene with acetaminophen(Darvocet-N 50, Darvocet-N 100) Oral | Mild to moderate pain, fever | Resembles narcotic in its mechanism and analgesic effect (propoxyphene); inhibits CNS prosta-glandin synthesis, producing analgesic effect (acetaminophen) (Nonnarcotic analgesic) | 2 tablets Darvocet-N 50 or 1 tablet Darvocet-N 100 every 4 hours | Nausea, vomiting, constipation, abdominal pain, sedation, dizziness, lightheadedness | |||||||
Oxycodone and aspirin (Percodan) Oral | Moderate to severe pain | Relieves pain, sedates, reduces fever | One tablet every 6 hours prn; give with food or with a full glass of water or milk | Dependence, respiratory depression (esp. in elderly), dizziness, drowsiness, gastrointestinal upset, constipation | |||||||
Pentazocine (Talwin) Oral, IM, subcutaneous, IV | Moderate to severe pain; preparation for surgery | Relieves pain, sedates | 50–100 mg every 3–4 hours po; 30 mg IM; caution patient to avoid alcohol and OTC drugs | Dependence, dizziness, drowsiness, euphoria, nausea, dyspnea, hypotension, dry mouth, urinary retention | |||||||
Meperidine (Demerol) IM, subcutaneous, IV, oral | Moderate to severe pain; preparation for surgery | Relieves pain, sedates | 50–100 mg every 3–4 hours prn orally or parenterally; may cause drowsiness; caution patient to avoid alcohol | Dependence, dizziness, drowsiness, nausea, flushing, sweating, dry mouth, orthostatic hypotension, seizures | |||||||
Anticonvulsants |
|
|
|
| |||||||
Clonazepam(Klonopin) Oral | Absence, akinetic, myoclonic seizures | Controls seizures without impairing the normal functioning of the central nervous system; selectively depresses the hyperactive areas of the brain that cause seizures | 0.5 mg tid, increase by 0.5–1 mg every 3 days until seizures under control | Rash, fever, headache, pain or swelling in the mouth, nose, urinary tract, sore throat, bruising, dark urine, loss of appetite, abdominal pain | |||||||
Gabapentin(Neurontin) Oral | Partial seizures | Controls seizures, anticonvulsant action unknown | 900–1800 mg/day in three divided doses | Somnolence, ataxia, dizziness, fatigue, nystagmus, tremor, nervousness, dysarthria, amnesia, depression, abnormal thinking, twitching, headache | |||||||
Phenytoin sodium (Dilantin) Oral, IV | Grand mal epilepsy; psychomotor seizures | Controls seizures | 300 mg/day divided every 8 hours for liquid oral and IV administration | Back-and-forth eye movements (nystagmus); diplopia (double vision); swollen, tender gums; staggering walk (ataxia); slurred speech; constipation; dizziness; nausea and vomiting; rashes, anemia, sedation | |||||||
Carbamazepine (Tegretol) Oral | Tonic-clonic seizures; other seizure types | Is a prophylactic treatment of seizures | 200 mg bid increased to 800–1200 mg/day; should not be used by pregnant women or nursing mothers | Dizziness, drowsiness, nausea, vomiting, ataxia, mouth sores | |||||||
Antiparkinsonian Drugs |
|
|
| ||||||||
Carbidopa and levodopa (Sinemet) Oral | Parkinson’s disease or Parkinsonlike symptoms | Reduces rigidity of head and limbs; is a dopaminergic(involving activity of a neurotransmitter) | Initial dose: 1 tablet (10 mg carbidopa/100 mg levodopa or 25/100) tid Maintenance dose: 1 or 2 tablets (25/250) tid, individually adjusted; watch for symptoms of depression; give with food; may cause drowsiness | Mood changes; unusual, uncontrolled body movements; palpitations; difficult urination; dry mouth; nausea; vomiting; orthostatic hypotension | |||||||
Benztropine mesylate (Cogentin) Oral, IM | Parkinson’s disease adjunct | Is an anticholinergic | 0.5–6 mg/day | Dry mouth, blurred vision, constipation, palpitations | |||||||
Alzheimer’s Drugs |
|
|
|
| |||||||
Donepezil (Aricept) Oral | Mild to moderate dementia of Alzheimer’s disease | Enhances cholinergic function by increasing levels of acetylcholine | 5 mg daily, may increase to 10 mg after 4–6 weeks | Nausea, vomiting, diarrhea, insomnia, dizziness, hypertension, headaches, muscle cramps, urinary incontinence, dyspnea | |||||||
Rivastigmine (Exelon) Oral | Mild to moderate dementia of Alzheimer’s disease | Enhances cholinergic function by increasing levels of acetylcholine | 1.5 mg bid | Nausea, vomiting, diarrhea, anorexia, weight loss, dizziness, headache, hypotension, rashes, arthritis, rhinitis, anemia | |||||||
Alzheimer’s Drugs |
|
|
|
| |||||||
Memantine (Namenda) Oral | Moderate to severe dementia of Alzheimer’s disease | Affinity as an antagonist for N-methyl-D-aspartate receptors, preventing activation of glutamate (an excitatory amino acid) | 5 mg daily; may increase in increment doses to 10 mg bid | Constipation, vomiting, melena, dizziness, headache, vertigo, hypertension, coughing, frequent micturition, cataracts, fatigue, pain | |||||||
Antimigraine Drugs |
|
|
| ||||||||
Ergotamine tartrate (Ergostat) Sublingual, inhalation | Migraine headaches | Alpha-adrenergic blocking agent | One 2 mg tablet or 1 inhalation at the first sign of an attack; may repeat every 30 minutes up to 6 mg daily or 6 inhalations | Nausea, vomiting, numbness, pain, weakness of extremities | |||||||
Sumatriptan succinate (Imitrex) Subcutaneous, oral, inhalation | Migraine headaches | Agonist for vascular 5–HT1 receptor subtype | 6 mg subcutaneously but no more than 12 mg in 24 hours; 25 mg, 50 mg, or 100 mg orally at onset of migraine; may repeat in 2 hours but not more than 200 mg daily; 5 mg, 10 mg, or 20 mg as a nasal spray; may repeat in 2 hours up to 40 mg daily | Angina pectoris, flushing, hyper- or hypotension, bradycardia, tachycardia, palpitations |
a Trade names given in parentheses are examples only. Check current drug references for a complete listing of available products.
b Average adult doses are given. However, dosages are determined by a physician and vary with the purpose of the therapy and the particular patient.
The doses presented in this text are for general information only.
Answers will vary depending on the edition of the PDR® used.